Two Sigma Investments’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-7,500
Closed -$1.95M 4056
2021
Q4
$1.95M Buy
7,500
+6,700
+838% +$1.74M ﹤0.01% 1936
2021
Q3
$211K Buy
+800
New +$219K ﹤0.01% 3932
2021
Q1
Sell
-2,300
Closed -$489K 4192
2020
Q4
$489K Buy
+2,300
New +$459K ﹤0.01% 2535
2020
Q3
Sell
-2,000
Closed -$384K 3487
2020
Q2
$384K Sell
2,000
-4,300
-68% -$704K ﹤0.01% 2201
2020
Q1
$928K Buy
6,300
+4,300
+215% +$685K 0.01% 1462
2019
Q4
$310K Sell
2,000
-900
-31% -$130K ﹤0.01% 3164
2019
Q3
$392K Buy
+2,900
New +$380K ﹤0.01% 2747

Other funds holding RMD

Two Sigma Investments's RMD Position: Q1 2026 in Review

Two Sigma Investments opened a new position in ResMed (RMD) in Q1 2026: 312,468 shares worth $70.1M. The stake represents 0.06% of the portfolio and ranks #382 among its holdings. This is a return to the name: Two Sigma Investments previously reported a position in RMD as recently as Q4 2023.

Two Sigma Investments first reported a position in RMD in Q2 2013 and has held it in 22 quarters since. The position peaked at $138M in Q3 2023. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Two Sigma Investments held 312,468 shares of ResMed worth $70.1M as of Q1 2026.
  • ResMed was a new Two Sigma Investments position in Q1 2026.
  • ResMed made up 0.06% of Two Sigma Investments's portfolio in Q1 2026, its #382 holding.
  • Two Sigma Investments first reported a position in ResMed in Q2 2013 and has held it in 22 quarters since.
  • Two Sigma Investments's ResMed position peaked at $138M in Q3 2023.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.